Home › Autoimmune Diseases › NCT04684602

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Age 18 and older
* Ability to provide informed consent
* Availability for follow up visits

Exclusion Criteria:

* Active or recent malignancy (within last 2 years)
* Pregnancy or breast-feeding
* Inability to provide informed consent

About the study

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

What is being tested

• PrimePro™/ PrimeMSK™ (biological)

Sponsor: Thomas Advanced Medical LLC · Participants: 5,000 · Started: Jul 9, 2020

Contact the study team

• Paul C Bogaardt, PhD(c), MSc, MBA · Phone: 866 864 7789
• Karen Mulholland Angelus · Phone: 866 864 7789

Official record on ClinicalTrials.gov — NCT04684602

Locations in the U.S.

Conditions

• Autoimmune Diseases
• Cardiovascular Disease
• Diabetes Complications
• Skin Conditions
• Degenerative Nerve Diseases
• Neurologic Diseases
• Lung Diseases
• Sexual Problems in Men
• Viral Infections
• Erectile Dysfunction
• Heart Diseases
• Mental Disorders
• Tauopathies
• Brain Diseases
• Dementia
• Cardiomyopathy
• Peripheral Nerve Disorders
• Alzheimer's Disease
• Immune System and Disorders
• Neuromuscular Disorders
• Post-COVID Conditions (Long COVID)

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.